Santhera Pharmaceuticals Aktie
17,34
EUR
-0,27
EUR
-1,52
%
16,08
CHF
+0,12
CHF
+0,75
%
Werbung
Santhera Pharmaceuticals Aktie Analyse
28.02.11 | Santhera Pharmaceuticals hold | Vontobel Research | |
18.02.11 | Santhera Pharmaceuticals hold | Vontobel Research | |
08.02.11 | Santhera Pharmaceuticals hold | Vontobel Research | |
25.10.10 | Santhera Pharmaceuticals hold | Vontobel Research | |
14.10.10 | Santhera Pharmaceuticals hold | Vontobel Research | |
14.09.10 | Santhera Pharmaceuticals hold | Vontobel Research | |
06.09.10 | Santhera Pharmaceuticals hold | Vontobel Research | |
03.09.10 | Santhera Pharmaceuticals hold | Vontobel Research | |
Werbung
|
|||
17.06.10 | Santhera Pharmaceuticals halten | Vontobel Research | |
16.06.10 | Santhera Pharmaceuticals halten | Vontobel Research | |
27.05.10 | Santhera Pharmaceuticals halten | Vontobel Research | |
21.05.10 | Santhera Pharmaceuticals halten | Vontobel Research | |
20.05.10 | Santhera Pharmaceuticals halten | Vontobel Research |
Werbung
Werbung